NIAID Site Search

Jordan Report: Accelerated Development of Vaccines (2012) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: December 31, 2012

Jordan Report: Accelerated Development of Vaccines (2007) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: August 6, 2019

2012 update from NIAID on vaccine research for specific infectious diseases including Dengue, SARS, West Nile Virus, HIV/AIDS, and others

Last Reviewed: January 1, 2013

Expert articles from Jordan Report: Accelerated Development of Vaccines (2012) from NIAID

Last Reviewed: December 31, 2012

Jordan Report: Accelerated Development of Vaccines (2002) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: December 31, 2002

SARS Vaccine Updates in the Jordan Report: Accelerated Development of Vaccines (2012) from NIAID

Last Reviewed: January 1, 2012

Nico Contreras, Ph.D., of University of Arizona, F31 sample application

Last Reviewed: March 31, 2025

Liu Application

Last Reviewed: November 5, 2024

Cellular mechanisms of chronic inflammation in vivo Cytokine and lipid mediator networks in inflammation Role of innate immune cells in pulmonary immune responses Lipid metabolism in inflammation and host resistance Inflammation-induced disease exacerbation

Last Reviewed: March 5, 2025

Last Reviewed: March 28, 2024

Sample application from David Al-Adra MD, Ph.D., for NIH standard independent research project grant (K08).

Last Reviewed: September 13, 2024

Last Reviewed: November 24, 2023

We are a group of dedicated scientists who work in a highly collaborative, team-oriented, and supportive environment. Together, we tackle difficult questions of chronic inflammation and innate immunity in lung diseases. Our experimental approach to query the immune system is to use animal models of pulmonary pathogens that affect thousands of Americans and millions of people worldwide.

Last Reviewed: March 4, 2025

The focus of the BIS is to understand the mechanisms that underly viral diseases. The work focuses, predominantly, on understanding the differential disease outcomes between natural hosts of immunodeficiency lentiviral infections and progressive infections. Our studies rely heavily on cellular and molecular immunological analyses in tissues.

Last Reviewed: February 28, 2025

Last Reviewed: November 24, 2023

Development of diagnostics tools to detect exposure to pathogens, insects, and ticks The host immune response to insect-borne pathogens Pathogen-insect interactions Field expertise in epidemiology and pathogen transmission of insect-borne diseases

Last Reviewed: February 26, 2025

In honor of National Postdoc Appreciation Week 2024, the NIAID Office of Research Training and Development is recognizing NIAID postdocs who enrich the NIAID training community through their outstanding mentorship. Read about the research contributions and mentoring philosophies of several NIAID postdocs who were nominated by their postbac mentees for their exemplary mentorship.

Published: September 16, 2024

Sample application from Steven W. Dow, D.V.M., Ph.D., for exploratory/developmental grant (R21).

Last Reviewed: May 22, 2024

Our basic immunological studies on macrophage biology and our translational research studies on the microbiota are converging toward understanding factors that regulate variation of type-2 immune responses in humans. Using mouse models, field and clinical studies, we plan to test on chromatin remodeling in macrophage responses to type-2 cytokines, as well as helminth-microbiota interactions.

Last Reviewed: September 28, 2022

The Vector Molecular Biology Section focuses on understanding how molecules from arthropod vectors are critical for the success of pathogen transmission and translating this knowledge into disease control opportunities.

Last Reviewed: September 27, 2022

Vincent Munster, Ph.D., is the Chief of the Virus Ecology Unit. The main objectives of our research program aim to identify the underlying biotic or abiotic changes in virus-host ecology that allow these emerging viral pathogens to cross the species barrier. Recognizing both the strengths and weaknesses of a unilateral focus on field research on one hand and experimental research on the other, we set out to combine the best of both approaches in one research program, where we aim to identify drivers of cross-species transmission from data gathered in the field and model these drivers under experimental conditions in the lab.

Last Reviewed: February 19, 2025

Office of Research on Women’s Health and NIH Support for Research on Women’s Health Report of the Advisory Committee on Research on Women’s Health: Fiscal Years 2019–2020 508-compliant PDF

Last Reviewed: March 8, 2022

National Institutes of Health // Food and Drug Administration // Immunology Interest Group

Last Reviewed: October 10, 2023

Sample application from Mengxi Jiang, Ph.D., for NIH standard independent research project grant (R01).

Last Reviewed: November 29, 2022

This document provides an overview of research and training programs opportunities for 2022-2023 available through the Division of Intramural Research.

Last Reviewed: November 3, 2022